Overview
Alessandro Sgambato practices in Rome, Italy. Mr. Sgambato is rated as an Experienced expert by MediFind in the treatment of Dihydropyrimidine Dehydrogenase Deficiency. His top areas of expertise are Colorectal Cancer, Colitis, Viral Gastroenteritis, Ependymoma, and Tissue Biopsy.
His clinical research consists of co-authoring 157 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Dihydropyrimidine Dehydrogenase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ColitisMr. Sgambato isAdvanced. Learn about Colitis.
- Colorectal CancerMr. Sgambato isAdvanced. Learn about Colorectal Cancer.
- EpendymomaMr. Sgambato isAdvanced. Learn about Ependymoma.
- Viral GastroenteritisMr. Sgambato isAdvanced. Learn about Viral Gastroenteritis.
- Experienced
- Adult Soft Tissue SarcomaMr. Sgambato isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Brain TumorMr. Sgambato isExperienced. Learn about Brain Tumor.
- Cerebral HypoxiaMr. Sgambato isExperienced. Learn about Cerebral Hypoxia.
- ChondrosarcomaMr. Sgambato isExperienced. Learn about Chondrosarcoma.
- Chronic B-Cell Leukemia (CBCL)Mr. Sgambato isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Sgambato isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).